Home
Latest
E-paper
Companies
Industry
Economy
Blueprint
Finance
Markets
Budget
India News
Politics
External Affairs Defence Security
World News
Opinion
Technology
Immigration
Specials
Partner Content
Sports
Cricket
Lifestyle
Entertainment
Social Viral
Health
BS Decoded
Books
Education
Newsletters
Web Stories
BS at 50
Multimedia
Sudoku
Crossword
BS Apps
Management
Indulgence
Premium
Explore Business Standard
BFSI Insight Summit
Events
About Us
BS Support
Popular Search
Resistant to strain
Novo Nordisk premium will survive drug wars
Get out of fail free
ECB's MPS kid gloves are a necessary evil
Darling buds of May
Assault on UK privilege has many possible targets
Gallic hug
French foray into Italian mobile will be hard slog
Brexit music
Italy first to exploit EU's new-found weakness
Io Brexit
Italy best to avoid sneaky bank bailout
Brexit hokey-kokey
How Europe can contain damage from Brexit
Kicking the kicking of the can
Greek deal is rational, predictable, messy
Far from prostrate
Sanofi bidding war looks expensive from the start
MDA comedown
CoCos can work, but the fix will be painful
Credit where it isn't due
When Mario Draghi buys, it's time to sell
Game of armchairs
Berlusconi, Bollore, Murdoch lock horns: who wins?
Still in Saipem
Italy ends up on wrong side of oil punt
High noon for high yield
Safe havens scarce in brewing high-yield storm
Half Marks
More Carney sounds better for BoE than for him
Selective binge
AstraZeneca's M&A flurry clears value hurdle
Dismantling Europe
Europe's least bad option: ditch Schengen
Your pain my gain
Mediobanca gets Barclays to pay for its own pivot
Political Viagra
Pfizer-Allergan gets no support from scaredy arbs
Betting on Bollore
Bollore's tilt at Telecom Italia board is too cheeky
 "Neil Unmack")
